Egypt allocates over $1bln to enhance healthcare facilities in 6 governorates
Egypt - At the annual forum of the Universal Health Insurance Authority in the New Administrative Capital, Prime Minister Mostafa Madbouly underscored Egypt's commitment to advancing healthcare.
Madbouly highlighted that the comprehensive health insurance system represents a major transformation, ensuring universal coverage through a social solidarity-based model. The state has dedicated substantial financial and human resources to this reform, prioritizing coverage for the most vulnerable.
Reaffirming that investing in healthcare is an investment in Egypt's future generations, Madbouly outlined key divs related to the comprehensive health insurance system. During the first phase, implemented in six governorates, over EGP 51bn was allocated to equip and upgrade healthcare facilities, benefiting six million citizens out of Egypt's 107 million population.
He noted that this expenditure indicates the expected costs required to complete the system, with approximately EGP 115bn projected to prepare the governorates in the second phase.
At the same time, he emphasized that Egypt is now entering a crucial new phase of implementation—the second phase—focused on expanding coverage. This stage underscores the state's dedication to accelerating execution, ensuring healthcare infrastructure readiness, upgrading medical facilities, and advancing digital solutions. It aims to integrate high-population governorates, enabling more efficient and sustainable healthcare services.
Through ambitious plans to develop hospitals, train medical professionals, and enhance service integration, the government seeks to guarantee universal access to quality healthcare, leveraging lessons learned from the first phase.
Madbouly stated that the second phase of the comprehensive health insurance system requires enhanced collaboration, integration, and effective partnerships. Following the successes of the first phase, the government is fully committed to preparing for the next stage, which will include the governorates of Damietta, Matrouh, Kafr El-Sheikh, Minya, and North Sinai. Additionally, consideration is being given to incorporating a major governorate that primarily relies on university hospitals, the private sector, and civil society for healthcare services.
Deputy Prime Minister for Human Development and Minister of Health and Population Khaled Abdel Ghaffar emphasized Egypt's dedication to enhancing private sector participation in the country's healthcare infrastructure development.
He highlighted the growing role of the private sector, noting that the share of private hospital beds increased from 21% in 2011 to 29.3% in 2022. Meanwhile, private hospitals now account for 63.3% of the total, up from 59% in 2011. This expansion reflects increasing confidence in private healthcare services and their crucial role in addressing rising medical care demands.
Additionally, the private sector holds a significant share in Egypt's pharmaceutical market, contributing approximately 82% in recent years.
At the forum, Stéphane Guimbert, the World Bank's Regional Director, praised Egypt's progress in reducing birth and mortality rates while increasing life expectancy.
He commended Egypt's achievement of the World Health Organization's Gold Certification for eliminating hepatitis C and acknowledged the government's 'remarkable' efforts in expanding universal health coverage. Guimbert affirmed the World Bank's pride in partnering with Egypt on this initiative.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
29-05-2025
- Zawya
Egypt's HoldiPharma partners with US-based Dawah Pharma to manufacture, export to global markets
Arab Finance: The state-owned pharmaceutical firm HoldiPharma signed a partnership agreement with US-based Dawah Pharma to establish a joint venture for the manufacturing and export of pharmaceuticals and nutritional supplements to international markets, including North America and Europe, as per a statement. The agreement was signed in the presence of Prime Minister Mostafa Madbouly, who emphasized that the deal reflects international confidence in Egyptian industry and fulfills presidential directives to bolster national strategic sectors, particularly pharmaceuticals. Under the agreement, the newly formed joint venture, 60% owned by Dawah Pharma and 40% by the Egyptian side, will begin with the export of six nutritional supplement products already approved for the US market. Future plans include manufacturing and exporting a wide range of pharmaceutical products, such as ampoules, sterile injections, ophthalmic preparations, and over-the-counter medications. The venture will utilize advanced pharmaceutical manufacturing technologies, including syrups, tablets, prefilled syringes, and transdermal patches. The company will also operate under the regulatory frameworks of the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), ensuring compliance and boosting the global competitiveness of Egyptian pharmaceutical products. © 2020-2023 Arab Finance For Information Technology. All Rights Reserved. Provided by SyndiGate Media Inc. (
Zawya
29-05-2025
- Zawya
Egypt, US partner to launch global pharmaceutical manufacturing, export venture
Egypt has signed a major joint venture agreement with US-based Dawah Pharma to manufacture and export pharmaceutical products and nutritional supplements to global markets, with a strategic focus on North America and Europe. The deal marks a significant milestone in Egypt's push to expand its pharmaceutical exports and attract foreign investment to its health sector. Prime Minister Mostafa Madbouly witnessed the signing ceremony, which took place in the presence of Deputy Prime Minister for Human Development and Minister of Health and Population Khaled Abdel Ghaffar, Minister of Public Enterprise Sector Mohamed El-Shimy, Head of the Egyptian Drug Authority Ali El-Ghamrawy, and Hisham Setit, Head of the Unified Procurement Authority for Medical Supplies and Technology. The agreement was signed by Ashraf El-Khouly, Executive Managing Director of the Egyptian Holding Company for Pharmaceuticals—affiliated with the Ministry of Public Enterprise Sector—and Hossam Abdel Maksoud, Chairman of Dawah Pharma. Prime Minister Madbouly said the agreement reflects Egypt's broader strategy to enhance national industries, with the pharmaceutical sector identified as a key priority. He described the partnership as a strong vote of confidence in the quality and potential of Egyptian manufacturing, particularly in the medical field. Minister El-Shimy emphasized that the partnership follows major investments to modernize the holding company's infrastructure, upgrade production lines, and align operations with international Good Manufacturing Practices (GMP). He described the venture as a pivotal step in Egypt's plan to boost pharmaceutical exports, strengthen international collaboration, and increase foreign direct investment. Under the agreement, the new joint venture will manufacture and export a wide range of products including ampoules, nutritional supplements, sterile injections, ophthalmic preparations, and over-the-counter (OTC) medications. The first phase will focus on exporting six pre-approved dietary supplements to the US market—an unprecedented move for the Holding Company for Pharmaceuticals, after meeting all relevant international regulatory and quality benchmarks. The venture will leverage state-of-the-art manufacturing technologies for a diverse range of dosage forms including syrups, tablets, ampoules, pre-filled syringes, and transdermal patches. This is expected to accelerate global market entry for Egyptian-made products and support long-term growth for the company and its subsidiaries. El-Shimy affirmed that the new company will comply with the most stringent international regulations, particularly those set by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to ensure the competitiveness of Egyptian products in North America, Europe, and emerging markets in Africa and Asia. As per the terms of the agreement, the Egyptian Holding Company for Pharmaceuticals will hold a 40% stake in the joint venture, while Dawah Pharma will own 60%. The partnership will also spearhead efforts to open new international markets for Egyptian pharmaceutical exports, solidifying Egypt's position as a regional hub for high-quality medical manufacturing. © 2024 Daily News Egypt. Provided by SyndiGate Media Inc. (
Zawya
15-05-2025
- Zawya
Egypt's President pushes for accelerated health, education reforms, AI integration
Egypt's President Abdel Fattah Al-Sisi held a series of high-level meetings on Wednesday to assess progress in Egypt's human development strategy, with a particular focus on healthcare, population policy, and education reform. Meeting with Prime Minister Mostafa Madbouly and Deputy Prime Minister for Human Development and Minister of Health and Population Khaled Abdel Ghaffar, the president reviewed initiatives under the National Project for Human Development. These efforts include the rollout of 300 integrated development centers, expansion of early childhood services through increased nursery capacity, and holistic programs targeting physical, mental, and social health—aligned with Egypt's Vision 2030. Presidential spokesperson Mohamed El-Shenawy reported that Minister Abdel Ghaffar provided updates on the national population strategy, part of the presidential 'Bedaya' initiative aimed at improving demographic indicators. Progress includes declines in child stunting, obesity, and anemia, alongside a projected reduction in the annual population growth rate to 1.34% in 2025, down from 1.4% the previous year. Al-Sisi also reviewed the status of healthcare infrastructure projects across 11 governorates. In FY 2025, Egypt will complete the construction or renovation of 20 hospitals at a cost of EGP 11.7bn, adding nearly 2,650 beds—including 458 intensive care, 442 neonatal, and 1,749 inpatient beds. These facilities will also be equipped with 542 dialysis units and 95 operating rooms, with completed projects in South Sinai, Gharbia, Minya, Qena, Assiut, Ismailia, and Aswan. The president received a briefing on Phase Two of the Universal Health Insurance System, which covers Damietta, Kafr El-Sheikh, Minya, Matrouh, and North Sinai. The plan includes upgrading 11 hospitals and constructing 19 new ones, with total capacity expected to reach 10,517 beds. Additionally, 534 new primary care units are being built, bringing the national total to 669. The estimated budget for this phase is EGP 115bn. Stressing the importance of timely and high-quality implementation, Al-Sisi also reviewed the national digital health transformation plan. Key elements include electronic health records, artificial intelligence integration, a national health information exchange, and global partnerships to ensure long-term sustainability. In a key directive, Al-Sisi instructed officials to explore the integration of artificial intelligence as a mandatory subject in school curricula—underscoring a shift toward future-focused education. The president also reviewed the progress of 15 presidential health initiatives covering all age groups. To date, more than 234 million health services have been delivered through 3,527 facilities. The 'Ending Surgical Waitlists' initiative has served nearly 2.7 million patients since 2018, and over 2.1 million individuals have received state-funded treatment in 2025 alone, costing EGP 23.2bn. The discussions also touched on Egypt's drive to localize pharmaceutical and medical device production. Al-Sisi called for new incentives to attract investment in this critical sector, aiming to meet domestic needs and expand exports. He also urged improvements in working conditions for healthcare professionals, along with greater access to advanced training—especially in AI-powered medical applications. In a separate meeting, Al-Sisi discussed educational reform with Minister of Education Mohamed Abdel Latif and Egyptian Military Academy Director Lt. Gen. Ashraf Salem Zaher. The talks focused on improving teacher selection and training, with new frameworks emphasizing academic, technical, and personal development through national institutions and training centers. Reaffirming the state's commitment to education reform, Al-Sisi emphasized the importance of developing the human element. 'Teachers are the cornerstone of the education system,' he said, calling for continued support, objective recruitment processes, and sustained investment in teacher development.
